Skip to main content

Advertisement

SpringerLink
Log in

Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients

  • Original Article
  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

Liver cirrhosis with hepatitis C viral infection (HCV-LC) causes high risk to develop hepatocellular carcinoma (HCC). Besides diagnosis of liver cirrhosis by biochemical test, imaging techniques, assessment of structural liver damage by biopsy shows several disadvantages. Our aim was to monitor the changes in the expression level of serum proteins and their glycosylation pattern among chronic hepatitis C (HCV-CH), HCV-LC and HCC patients with respect to controls. 2D gel electrophoresis of HCV-CH, HCV-LC and HCC patients’ sera showed several protein spots, which were identified by LC-MS. The change in the expression of two prominent protein spots, haptoglobin (Hp) and alpha 1-antitrypsin (AAT) was evaluated by western blot and ELISA. The changes in glycosylation pattern of these serum proteins were assayed using different lectins. Increased level of Hp and AAT was observed in HCV-LC and HCC patients’ group whereas those were found to be present less in HCV-CH patient groups with respect to control as determined by ELISA using monoclonal antibodies. Decreased level of sialylation in both Hp and AAT was observed in HCV-LC and HCV-CH patients’ group whereas increased level of sialylation was observed in HCC patient groups by ELISA using Sambucus nigra agglutinin. On the other hand increased level of fucosylation in two serum glycoproteins was observed in HCV-LC and HCC patients’ group using Lens culinarris agglutinin. High glycan branching was found in HCV-LC and HCC patient groups in Hp but not in HCV-CH as determined by Datura stramonium agglutinin. However, there was no such change observed in glycan branching in AAT of HCV-CH and HCV-LC patients’ groups, to the contrary high glycan branching was observed in HCC patients’ group. Increased level of exposed galactose in both serum proteins was observed in both HCC patients’ group as determined by Ricinus communis agglutinin. The present glycoproteomics study could predict the progression of HCV-CH, HCV-LC and HCC without the need of liver biopsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Di Bisceglie A.M.: Hepatocellular carcinoma: molecular biology of its growth and relationship to hepatitis B virus infection. Med. Clin. North Am. 73, 985–997 (1989)

    Article  PubMed  Google Scholar 

  2. Block T.M., Mehta A.S., Fimmel C.J., Jordan R.: Molecular viral oncology of hepatocellular carcinoma. Oncogene. 22, 5093–5107 (2003)

    Article  CAS  PubMed  Google Scholar 

  3. Marrero J.A.: Hepatocellular carcinoma. Curr. Opin. Gastroenterol. 22, 248–253 (2006)

    Article  PubMed  Google Scholar 

  4. Sallie R., Di Bisceglie A.M.: Viral hepatitis and hepatocellular carcinoma. Gastroenterol. Clin. N. Am. 23, 567–579 (1994)

    CAS  Google Scholar 

  5. Lok A., McMahon B.: Chronic hepatitis B. Hepatology. 34, 1225–1241 (2001)

    Article  CAS  PubMed  Google Scholar 

  6. El Serag H.B., Mason A.C., Key C.: Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology. 33, 62–65 (2001)

    Article  PubMed  Google Scholar 

  7. Sarbah S.A., Gramlich T., Younoszai A., Osmack P., Goormastic M., Grosso L., Cooper J.N., Di Bisceglie A., Seneca R., Younossi Z.M.: Risk factors for hepatocellular carcinoma in patients with cirrhosis. Dig. Dis. Sci. 49, 850–853 (2004)

    Article  CAS  PubMed  Google Scholar 

  8. Fattovich G., Stroffolini T., Zagni I., Donato F.: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterol. 127, S35–S50 (2004)

    Article  Google Scholar 

  9. Sheth S.G., Flamm S.L., Gordon F.D., Chopra S.: AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 93, 44–48 (1998)

    Article  CAS  PubMed  Google Scholar 

  10. Williams A.L., Hoofnagle J.H.: Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to Cirrhosis. Gastroenterol. 95, 734–739 (1988)

    CAS  Google Scholar 

  11. Lok A.S., McMahon B.J.: Practice Guidelines Committee, American association for the study of liver diseases (AASLD). Chronic Hepatitis B: Update of Recommendations. Hepatology. 39, 857–861 (2004)

    PubMed  Google Scholar 

  12. Saldova R., Wormald M.R., Dwek R.A., Rudd P.M.: Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis. Markers. 25, 219–232 (2008)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Peracaula R., Tabares G., Royle L., Harvey D.J., Dwek R.A., Rudd P.M., de Llorens R.: Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology. 13, 457–470 (2003)

    Article  CAS  PubMed  Google Scholar 

  14. Wada Y., Dell A., Haslam A.S., et al.: Comparison of methods for profiling O-glycosylation: human proteome organization human disease glycomics/proteomics multi-institutio9nal study of IgA1. Mol. Cell. Proteomics. 9, 719–727 (2010)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Varki A.: Biological roles of oligosaccharides: all of the theories are correct. Glycobiology. 3, 97–130 (1993)

    Article  CAS  PubMed  Google Scholar 

  16. Parekh R.B., Dwek R.A., Sutton B.J., Fernandes D.L., Leung A., Stanworth D., Rademacher T.W., Mizuochi T., Taniguchi T., Matsuta K., Takeuchi F., Nagano Y., Miyamoto T., Kobata A.: Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 316, 452–457 (1985)

    Article  CAS  PubMed  Google Scholar 

  17. Omtvedt L.A., Royle L., Husby G., Sletten K., Radcliffe C.M., Harvey D.J., Dwek R.A., Rudd P.M.: Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthr. Rheum. 54, 3433–3440 (2006)

    Article  CAS  Google Scholar 

  18. Dube R., Rook G.A., Steele J., Brealey R., Dwek R., Rademacher T., Lennard-Jones J.: Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut. 31, 431–434 (1990)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Thompson S., Dargan E., Turner G.A.: Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer. Cancer Lett. 66, 43–48 (1992)

    Article  CAS  PubMed  Google Scholar 

  20. Saldova R., Royle L., Radcliffe C.M., Abd Hamid U.M., Evans R., Arnold J.N., Banks R.E., Hutson R., Harvey D.J., Antrobus R., Petrescu S.M., Dwek R.A., Rudd P.M.: Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology. 17, 1344–1356 (2007)

    Article  CAS  PubMed  Google Scholar 

  21. Otake Y., Fujimoto I., Tanaka F., Nakagawa T., Ikeda T., Menon K.K., Hase S., Wada H., Ikenaka K.: Isolation and characterization of an N-linked oligosaccharide that is significantly increased in sera from patients with non-small cell lung cancer. J. Biochem. (Tokyo). 129(537–452), (2001)

  22. Kossowska B., Ferens-Sieczkowska M., Gancarz R., Passowicz-Muszynska E., Jankowska R.: Fucosylation of serum glycoproteins in lung cancer patients. Clin. Chem. Lab. Med. 43, 361–369 (2005)

    Article  CAS  PubMed  Google Scholar 

  23. Turner G.A.: Haptoglobin. A potential reporter molecule for glycosylation changes in disease. Adv. Exp. Med. Biol. 376, 231–238 (1995)

    Article  CAS  PubMed  Google Scholar 

  24. Okuyama N., Ide Y., Nakano M., Nakagawa T., Yamanaka K., Moriwaki K., Murata K., Ohigashi H., Yokoyama S., Eguchi H., Ishikawa O., Ito T., Kato M., Kasahara A., Kawano S., Gu J., Taniguchi N., Miyoshi E.: Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer. 118, 2803–2808 (2006)

    Article  CAS  PubMed  Google Scholar 

  25. Comunale M.A., Lowman M., Long R.E., Krakover J., Philip R., Seeholzer S., Evans A.A., Hann H.W., Block T.M., Mehta A.S.: Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J. Proteome Res. 5, 308–315 (2006)

    Article  CAS  PubMed  Google Scholar 

  26. Thompson S., Matta K.L., Turner G.A.: Changes in fucose metabolism associated with heavy drinking and smoking: a preliminary report. Clin. Chim. Acta. 201, 59–64 (1991)

    Article  CAS  PubMed  Google Scholar 

  27. Mann A.C., Record C.O., Self C.H., Turner G.A.: Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease. Clin. Chim. Acta. 227, 69–78 (1994)

    Article  CAS  PubMed  Google Scholar 

  28. Kondo M., Hada T., Fukui K., Iwasaki A., Higashino K., Yasukawa K.: Enzyme-linked immunosorbent assay (ELISA) for aleuria aurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronic hepatitis. Clin. Chim. Acta. 243, 1–9 (1995)

    Article  CAS  PubMed  Google Scholar 

  29. Hada T., Kondo M., Yasukawa K., Amuro Y., Higashino K.: Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein. Clin. Chim. Acta. 281, 37–46 (1999)

    Article  CAS  PubMed  Google Scholar 

  30. Hansen J.E., Iversen J., Lihme A., Bog-Hansen T.C.: Acute phase reaction, heterogeneity, and microheterogeneity of serum proteins as nonspecific tumor markers in lung cancer. Cancer. 60, 1630–1635 (1987)

    Article  CAS  PubMed  Google Scholar 

  31. Mondal G., Chatterjee U., Das H.R., Chatterjee B.P.: Enhanced expression of α1-acid glycorptein and fucosylation in hepatitis B patients provides an insight into pathogenesis. Glycoconj. J. 26, 1225–1234 (2009)

    Article  CAS  PubMed  Google Scholar 

  32. Mondal G., Chatterjee U., Chawla Y.K., Chatterjee B.P.: Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients. Glycoconj. J. 28, 1–9 (2011)

    Article  CAS  PubMed  Google Scholar 

  33. Bradford M.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254 (1976)

    Article  CAS  PubMed  Google Scholar 

  34. Saroha A., Biswas S., Chatterjee B.P., Das H.R.: Altered glycosylation and expression of plasma alpha-1-acid glycoprotein and haptoglobin in rheumatoid arthritis. J. Chromatogr. B. 879, 1839–1843 (2011)

    Article  CAS  Google Scholar 

  35. Shevchenko A., Wilm M., Vorm O., Mann M.: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850–858 (1996)

    Article  CAS  PubMed  Google Scholar 

  36. Rukmangadachar L.A., Kataria J., Hariprasad G., Samantaray J.C., Srinivasan A.: Two dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients. Clin. Proteom. 8, 4 (2011)

    Article  CAS  Google Scholar 

  37. Saroha A., Kumar S., Chatterjee B.P., Das H.R.: Jacalin bound O-glycoprotein profiling and reduced sialylation of plasma alpha 2-HS glycoprotein (A2HSG) in rheumatoid arthritis patients. PLoS one. 7, e46374 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Bose P.P., Mandal G., Kumar D., Duseja A., Chatterjee B.P.: Visual detection of serum asialohaptoglobin by plasmonic sandwich ELLSA – a new platform for cirrhosis diagnosis. Analyst. 141, 76–84 (2016)

    Article  CAS  PubMed  Google Scholar 

  39. Huang H.L., Stasyk T., Morandell S., Dieplinger H., Falkensammer G., Griesmacher A., Mogg M., Schreiber M., Feuerstein I., Huck C.W., Stecher G., Bonn G.K., Huber L.A.: Biomarker discovery in breast cancer serum using 2D differential gel electrophoresis/MALDITOF/TOF and data validation by routine clinical assays. Electrophoresis. 27, 1641–1650 (2006)

    Article  CAS  PubMed  Google Scholar 

  40. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y.: Poynard, T, MULTIVIRC Group.: biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 357, 1069–1075 (2001)

    Article  CAS  PubMed  Google Scholar 

  41. Poynard T., Imbert-Bismut F., Ratziu V., Chevret S., Jardel C., Moussalli J., Messous D., Degos F.: GERMED cyt04 group.: Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J. Viral Hepat. 9, 128–133 (2002)

    Article  CAS  PubMed  Google Scholar 

  42. Meliconi R., Parracino O., Facchini A., Morselli-Labate A.M., Bortolotti F., Tremolada F., Martuzzi M., Miglio F., Gasbarrini G.: Acute phase proteins in chronic and malignant liver diseases. Liver. 8, 65–74 (1988)

    Article  CAS  PubMed  Google Scholar 

  43. Borsotti M., De Philippis C., Leoncini F., Mazzotta F., Paci F., Piazza E., Spadolini M.P.: Changes in the serum protein picture in viral hepatitis. II. Evaluation of the Proteins in the Acute Phase. Quad Sclavo Diagn. 16, 385–401 (1980)

    CAS  PubMed  Google Scholar 

  44. Pateva R., Koichev K., Vurbanov G., Rusinov E., Danev I.: Complex study of glycoproteins in liver disease. Vutreshni Bolesti. 21, 65–69 (1982)

    CAS  PubMed  Google Scholar 

  45. Henke J., Kellner S., Kasulke D.: Haptoglobin- and group-specific component-phenotypes in healthy carriers of antibodies to hepatitis B surface antigen. Blut. 36, 109–110 (1978)

    Article  CAS  PubMed  Google Scholar 

  46. Xu-Fei T., Shan-Shan W., Shu-Ping L., Zhi C., Feng C.: Alpha-1 antitrypsin is a potential biomarker. Virol. J. 8, 274–280 (2011)

    Article  Google Scholar 

  47. Daiger S.P., Schanfield M.S., Cavalli-Sforza L.L.: Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc. Natl. Acad. Sci. U. S. A. 72, 2076–2080 (1975)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Yamamoto N., Homma S., Haddad J.G., Kowalski M.A.: Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells. Immunol. 74, 420–424 (1991)

    CAS  Google Scholar 

  49. Gomme P.T., J.Bertolini .: Therapeutic potential of vitamin D-binding protein. Trends Biotechnol. 22, 340–345 (2004)

  50. Stokes C.S., Volmer D.A., Grunhage F., Lammert F.: Vitamin D in chronic liver disease. Liver Int. 33, 338–352 (2013)

    Article  CAS  PubMed  Google Scholar 

  51. Schiodt F.V., Bangert K., Shakil A.O.: McCashland T, Murray N, hay JE. Lee WM: Predictive Value of Actin-Free Gc-Globulin in Acute Liver Failure. Liver Transpl. 13(1324–1329), (2007)

  52. Bouillon R., Auwerx J., Dekeyser L., Fevery J., Lissens W., De Moor P.: Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J. Clin. Endocrinol. Metab. 59, 86–89 (1984)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors sincerely thank Dr. Hari Prasad, Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India for providing the facility of LC-MS. GM is thankful to Indian Council of Medical Research, New Delhi for providing fellowship (45/2/2013-BIO/BMS). BPC acknowledges Indian Science congress Association for Sir Asutosh Mukherjee fellowship (2310/73/2013-14).

Author information

Authors and Affiliations

  1. Department of Natural Sciences, West Bengal University of Technology, Salt Lake, Kolkata, 700064, India

    Gautam Mondal & B. P. Chatterjee

  2. Genomics and Molecular Medicine Division, CSIR- Institute of Genomics and Integrative Biology, Delhi, India

    Ashish Saroha

  3. Department of Molecular Medicine, Bose Institute, P 1/12, CIT Road, Kolkata, 700054, India

    Partha Pratim Bose

Authors
  1. Gautam Mondal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ashish Saroha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Partha Pratim Bose
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. P. Chatterjee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. P. Chatterjee.

Electronic supplementary material

ESM 1

(PDF 779 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mondal, G., Saroha, A., Bose, P.P. et al. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients. Glycoconj J 33, 209–218 (2016). https://doi.org/10.1007/s10719-016-9658-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10719-016-9658-2

Keywords

Search

Navigation